We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $65.13 · 8 analysts
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Stored first · Google News · Yahoo Finance (English)
Assessing Liquidia (LQDA) Valuation After A Sharp 1 Year Shareholder Return - simplywall.st
Assessing Liquidia (LQDA) Valuation After A Sharp 1 Year Shareholder Return simplywall.st
LQDA News | LIQUIDIA CORP (NASDAQ:LQDA) - ChartMill
LQDA News | LIQUIDIA CORP (NASDAQ:LQDA) ChartMill
LQDA Stock Price, Quote & Chart | LIQUIDIA CORP (NASDAQ:LQDA) - ChartMill
LQDA Stock Price, Quote & Chart | LIQUIDIA CORP (NASDAQ:LQDA) ChartMill
Liquidia (NASDAQ:LQDA) CEO Roger Jeffs Sells 6,428 Shares - MarketBeat
Liquidia (NASDAQ:LQDA) CEO Roger Jeffs Sells 6,428 Shares MarketBeat
Entity linked to Liquidia (LQDA) CEO sells 6,428 shares in plan trade - Stock Titan
Entity linked to Liquidia (LQDA) CEO sells 6,428 shares in plan trade Stock Titan
Liquidia Corporation (LQDA) Leads Healthcare Stocks with 66.11% Gains - GuruFocus
Liquidia Corporation (LQDA) Leads Healthcare Stocks with 66.11% Gains GuruFocus
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 12. | After market close (AMC) | $0.84 | — | — | $170.98M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $-0.45 | — | — | $3.12M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $-1.17 | — | — | $11.08M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $-0.78 | — | — | $6.63M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2024. 10. 16. | Scotiabank | — | Initiate coverage | — → Sector Outperform | — | Scotiabank: Sector Outperform |
| 2024. 10. 03. | LifeSci Capital | — | Initiate coverage | — → Outperform | — | LifeSci Capital: Outperform |
| 2024. 08. 23. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2024. 08. 23. | Needham | — | Maintain | Buy → Buy | — | Needham: Buy |
| 2024. 08. 20. | BTIG | — | Maintain | Buy → Buy | — | BTIG: Buy |
| 2024. 08. 20. | B of A Securities | — | Maintain | Buy → Buy | — | B of A Securities: Buy |
As of FY2026Q1 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 563,233 | $21.26B | 0.02% | — | New position |
| 2 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 350,048 | $12.07B | 0.02% | — | New position |